Effects of volatile anaesthetics on human neutrophil oxidative response to the bacterial peptide FMLP.
Fröhlich
D
D
Department of Anaesthesia, University of Regensburg, Germany.
Rothe
G
G
Schwall
B
B
Schmid
P
P
Schmitz
G
G
Taeger
K
K
Hobbhahn
J
J
D000328:Adult; D018685:Anesthetics, Inhalation / Q000494:pharmacology*; D018929:Cell Culture Techniques; D000077335:Desflurane; D004305:Dose-Response Relationship, Drug; D004737:Enflurane / Q000494:pharmacology; D004987:Ethers / Q000494:pharmacology; D006221:Halothane / Q000494:pharmacology; D006801:Humans; D007530:Isoflurane / Q000031:analogs & derivatives / Q000494:pharmacology; D008738:Methyl Ethers; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology*; D018375:Neutrophil Activation / Q000187:drug effects* / Q000502:physiology; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism; D016897:Respiratory Burst / Q000187:drug effects*; D000077149:Sevoflurane
D018685:Anesthetics, Inhalation; D004987:Ethers; D008738:Methyl Ethers; D000077149:Sevoflurane; D009240:N-Formylmethionine Leucyl-Phenylalanine; D004737:Enflurane; D000077335:Desflurane; D007530:Isoflurane; D006221:Halothane